EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Daraxonrasib: The first-in-class RAS(ON) multi-selective inhibitor approved for treatment of metastatic pancreatic adenocarcinoma

Yueyi Sun, Chen Pang, Jianjun Gao

Drug Discoveries & Therapeutics · 31.10.2026 · 20 (5) · 400-402

DOI: 10.5582/ddt.2026.01067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 31.10.2026. Verfasst von Yueyi Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma, Antineoplastic Agents, Benzamides. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAdenocarcinomaAntineoplastic AgentsBenzamidesras ProteinsCarcinoma, Pancreatic DuctalHumansPiperazines

Stichwörter der Autor:innen

RASRASolute 302daraxonrasibpancreatic ductal adenocarcinomapneumonitis

Substanzen

Antineoplastic AgentsBenzamidesras ProteinsdaraxonrasibPiperazines

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.

Zitieren

APA

Sun, Y., Pang, C., & Gao, J. (2026). Daraxonrasib: The first-in-class RAS(ON) multi-selective inhibitor approved for treatment of metastatic pancreatic adenocarcinoma. Drug Discoveries & Therapeutics, 20(5), 400-402. https://doi.org/10.5582/ddt.2026.01067

Vancouver

Sun Y, Pang C, Gao J. Daraxonrasib: The first-in-class RAS(ON) multi-selective inhibitor approved for treatment of metastatic pancreatic adenocarcinoma. Drug Discoveries & Therapeutics. 2026;20(5):400-402. doi:10.5582/ddt.2026.01067

BibTeX
@article{Sun2026,
  author = {Sun, Yueyi and Pang, Chen and Gao, Jianjun},
  title = {Daraxonrasib: The first-in-class RAS(ON) multi-selective inhibitor approved for treatment of metastatic pancreatic adenocarcinoma},
  journal = {Drug Discoveries & Therapeutics},
  year = {2026},
  volume = {20},
  number = {5},
  pages = {400--402},
  doi = {10.5582/ddt.2026.01067}
}
Kostenlos starten →